JRCT ID: jRCT2080222971
Registered date:28/09/2015
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Thrombocytopenia due to chronic liver disease |
Date of first enrollment | 28/09/2015 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : S-888711 INN of investigational material : Lusutrombopag Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Safety, pharmacokinetic, efficacy |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Main inclusion criteria Thrombocytopenic patients with chronic liver disease undergoing invasive procedures |
Exclude criteria | Main exclusion criteria Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment |
Related Information
Primary Sponsor | Shionogi & Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-153023 |
Contact
Public contact | |
Name | |
Address | http://www.shionogi.co.jp/information/inquiry_entrance.html |
Telephone | |
Affiliation | Shionogi & Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |